This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.
Company Filing History:
1 out of 834,411 Years Active: 2003
Title: Jeffrey M Ostrove: Innovator in Carcinogen Assays
Introduction
Jeffrey M Ostrove is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of carcinogen detection through his innovative methods and assays. His work focuses on the early determination of whether a test agent is a carcinogen, which is crucial for public health and safety.
Latest Patents
Ostrove holds a patent for a method titled "Carcinogen assay." This invention involves novel methods and assays that correlate the pattern of differential gene expression from mammalian cells treated with a test agent to reference patterns from cells treated with known carcinogens. The patent also includes methods for using DNA and RNA isolated from treated cells, as well as kits that comprise these materials. Additionally, it outlines methods for determining carcinogenicity by measuring protein synthesis or post-translational modifications in treated mammalian cells.
Career Highlights
Throughout his career, Ostrove has demonstrated a commitment to advancing scientific knowledge in the field of carcinogen detection. His innovative approaches have the potential to significantly impact cancer research and toxicology.
Collaborations
Ostrove has collaborated with esteemed colleagues such as Robert E Bird and David Jacobson-Kram. These partnerships have likely contributed to the development and refinement of his patented methods.
Conclusion
Jeffrey M Ostrove's work in carcinogen assays exemplifies the importance of innovation in the field of health and safety. His contributions are vital for the early detection of potential carcinogens, which can lead to better preventive measures and improved public health outcomes.